Colorado Springs, United States
DNA ConneXions is a biotechnology and healthcare startup based in the United States, striving to empower individuals to take control of their health. The company operates as a Biosafety level 2 laboratory with a CLIA license, specializing in bacteriology, mycology, virology, routine chemistry, and toxicology testing. DNA ConneXions offers an innovative range of panels utilizing the molecular technique of polymerase chain reaction (PCR) to amplify human DNA, resulting in exceptionally sensitive and specific results. These panels include the Lyme Panel, Comprehensive Oral Panel, Propensity Panel, Apolipoprotein E (ApoE) Genotype Panel, and Gluten Intolerance Panel.
While the founding date and specific investment details are not available at present, DNA ConneXions presents a promising investment opportunity within the biotechnology and healthcare industries. With its focus on cutting-edge molecular techniques and comprehensive testing panels, the startup holds the potential to make a significant impact on the future of personalized health management. Investors seeking exposure to innovative advancements in diagnostics and health empowerment would find DNA ConneXions a compelling prospect for strategic investment and growth within the evolving healthcare landscape.
